Sage Therapeutics CEO: Getting the first postpartum depression drug approved
Share

Sage Therapeutics CEO: Getting the first postpartum depression drug approved

Jim Cramer talks with Sage Therapeutics CEO Jeff Jonas about the biopharma company's Zulresso drug for postpartum depression and how it could help mothers.
06:42
Wed, Mar 20 20197:05 PM EDT